Researchers strive to find optimal approach for reducing toxicities resulting from graft-versus-host-disease prophylaxis treatment.
Read MoreA Germline Biomarker Offers Insight Into Treatment Selection for Men With Prostate Cancer
Research study aims to identify biomarkers for predicting response to prostate cancer treatment.
Symptom Resolution Achieved in More than 90 Percent of Patients Under Palliative Care
Palliative medicine physician David Harris, MD, discusses best practices and recent advances in managing gastrointestinal symptoms in patients with cancer.
Low-Dose Radiation Therapy Reemerging for Osteoarthritis
Use of low-dose radiation a non-invasive treatment for certain types of osteoarthritis
Studying Ultra-Hypofractionated Radiotherapy for Soft Tissue Sarcoma
Research team found ultra-hypofractionated radiotherapy improved on the current standard of care for treating soft tissue sarcoma.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Paget’s Disease of the Breast a Little Understood Form of DCIS
Breast Surgery Specialist Stephanie Valente, DO, discusses the diagnosis and treatment of Paget’s disease, a rare form of ductal carcinoma in situ that may look like eczema or psoriasis of the nipple and areola.
Cleveland Clinic Cancer Center and National Organization for Rare Disorders Partner to Accelerate Diagnosis and Treatment of Rare Cancers
Cleveland Clinic’s Director of Rare Cancers and Blood Diseases explains how having a formalized system in place for treating rare cancers can shorten the diagnostic odyssey and help improve patient outcomes and quality of life.
p53-Independent Non-Cytotoxic Therapy May be a Viable Option for Chemotherapy-Resistant Small Cell Lung Cancer
Researchers delve into the origins of drug resistance in small cell lung cancer.
The Role of Immune Escape in Post-Transplant Leukemia Relapse
New study yields clues to the cause of relapse after bone marrow transplant in patients with certain types of leukemia.
Cleveland Clinic Lerner Research Institute to Host Head & Neck Cancer CME Symposium
CME program features advances and best practices in treating head and neck cancers.
Adding EGFR-Directed Systemic Treatment of Stereotactic Radiosurgery May Improve Control of Brain Metastases in Non-Small Cell Lung Cancer
Combining stereotactic radiosurgery with an epidermal growth factor receptor-tyrosine kinase inhibitor may benefit patients with brain metastases from NSCLC but further study is needed to change standard of care.